Print Page   |   Contact Us
Community Search
PCSS-O Webinar: Demystifying Drug Interactions with Combined Analgesics Across Therapeutic Classes
Tell a Friend About This EventTell a Friend
 

About the webinar: Considering drug-drug interactions is key to selecting the safest and most efficacious combinations of analgesic drug classes and adjuvants (e.g., antidepressants, anticonvulsants). To appropriately identify drug-drug interactions, it is essential clinicians understand the relevant common mechanisms for these, in particular those mediated by the cytochrome P450 (CYP450) system and P-glycoprotein.

9/19/2017
When: Tuesday| September 19, 2017 | 2:30 pm - 3:30 pm ET
Where: United States

« Go to Upcoming Event List  

Interactive PCSS Projects Brochure. Share the link!

 

 

 

 

PCSS-O Upcoming Live Webinar

 

Demystifying Drug Interactions with Combined Analgesics Across Various Therapeutic Classes

 

 

Tuesday| September 19, 2017 | 2:30 pm - 3:30 pm ET

 

Presenters:Larry C. Driver, MD; Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP

 

Sponsor:American Academy of Pain Medicine (AAPM)

 

About the webinar:Considering drug-drug interactions is key to selecting the safest and most efficacious combinations of analgesic drug classes and adjuvants (e.g., antidepressants, anticonvulsants). To appropriately identify drug-drug interactions, it is essential clinicians understand the relevant common mechanisms for these, in particular those mediated by the cytochrome P450 (CYP450) system and P-glycoprotein. Pharmacogenetic differences among patients can also impact efficacy, drug interactions, and ability to tolerate medications. This webinar will describe opioid and non-opioid pharmacokinetics and drug-drug interactions and their impact on patient analgesia. Adverse effects when combining analgesics will be further explored through cases studies.

 

Educational objectives:

· Classify cytochrome P450 (CYP450) system nomenclature and describe role of CYP450 and p-glycoprotein in pharmacokinetics.

· Recognize key CYP450 mediated drug-drug interactions.

· Identify potential drug-drug interactions and important considerations when prescribing various analgesic classes and adjuvants.

 

Accreditation and designation:The American Academy of Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

The American Academy of Pain Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

Funding for this initiative was made possible (in part) by grant no. 5H79TI025595-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 

Twitter

Sign In
Sign In securely
Classified Ads